UK Markets close in 4 hrs 6 mins

GlaxoSmithKline plc (GSK.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
1,429.00+10.00 (+0.70%)
As of 4:39PM BST. Market open.
Sign in to post a message.
  • d
    If you haven’t made investment yet, there is still time because this coin Ethereum is a rocket ship. Never mind the beatdown that it is taking on now, the big boys know where they will take this and so is Bitcoin. I have read all day long that Bitcoin is making new highs and so is Ether. Mr. Davies hill Trade is a crypto trader who assists new babies in making investments and earning good profits. He can be reached on
    Teleg^^m @daviestrade
    Whats>>>Âpp +1 (609) 438-1811
  • K
    Insiders at GlaxoSmithKline Have Bought Stock Recently
    It's good to see that GlaxoSmithKline insiders have made notable investments in the company's shares. In the last 3 months, four insiders shelled out UK£70k for shares in the company -- and none sold. This is a positive in our book as it implies some confidence.

    When we dig a bit deeper, we can see that besides the separation of the company, GSK has a rich pipeline of potential vaccines that are in various stages of clinical development. The estimated success of these vaccines could be pertly the reason why insiders are still buying the stock.
  • E
    Time to buy "value" stocks like GSK !!!

    # 1vaccine maker in the World
    #1 healthcare product in the World ....bigger than JNJ
    # 1 in HIV treatment
  • e
    eduardo r
    Enlight me, please. The reason for today's behavior?
  • R
    Under Dame Emma Walmsley's leadership the GSK stock price is back to where we started in January. That is the New GSK.............
  • S
    broke my $39 support level. my feeling is it's headed lower before going higher.
  • e
    eduardo r
    Be prepared for a jump after the Aukus Pact news impact dilutes and we go back to normal . Haven't read the news in deep but I suppose this was the market maker today. GSK is performing exceptionally well at this point.
  • l
    Hi guys, just posting to see if i can gather anyones thoughts or experiences with pre IPO's? Ive been dabbling with a company called SpectrumX which is making its IPO in November and is a similar Pharma to GSK. Looks like a promising investment but need thoughts on whether pre IPO's are worth it?
  • e
    eduardo r
    The Aukus Pact was a necessity. Finally, the world has woken up. Congratulation to free World Leaders. Booo to China, Rusia, and Rogue States.
  • J
    Under $40 again. Is this the beginning of a big drop or just a resting place on the way to $50??
  • h
    GSK monoclonal antibody taking off in US with Gov Desantis purchase for Florida.
  • e
    eduardo r
    Long trend 200 ma up ( unchanged). Won't be under 50 ma for long.
  • T
    I'm in at $39 today.
  • J
    Short Ratio is almost as high as the dividend yield.
  • e
    eduardo r
    GSK is basically a" Non -split corporation". That means you get the whole pizza when you buy its share and not just a slice or just a fraction.
    An example: Pfizer has split 5 times from 1983 to 1999, it halved 4 times it 2x1 and even worse 3x1 in 1999.

    Another example: J&J has split 4 times from 1981 to 1992. 3 times 2x1 and once 3x1,
    A close peer AZN split 3x1 in 1998 so basically, after that, you would get one-third of its original value if you bought the share after that year.
    " A stock split is a decision by a company's board of directors to increase the number of shares that are outstanding by issuing more shares to current shareholders.

    For example, in a 2-for-1 stock split, an additional share is given for each share held by a shareholder. So, if a company had 10 million shares outstanding before the split, it will have 20 million shares outstanding after a 2-for-1 split.

    A stock's price is also affected by a stock split. After a split, the stock price will be reduced (since the number of shares outstanding has increased).

    So in my opinion this stock has been historically been unfairly disregard by investors.
  • C
    Can anyone explain the spin-off to me? Or let me know if the below is correct?

    GSK will sell 80% of its 68% share of their leading consumer health arm that is split with Pfizer for a one time payment of ~8B. They will retain 20% stake in the new entity for a short period and will sell that remaining stake down the road.

    My question is, why is this so appealing when the consumer health division leads market share and brings in 10B in revenue? What is Elliot Management so interested in?
  • C
    Cid Rock
    I hope you guys are right here about glaxo. I made a big mistake with novax
  • a
    GSK is performing super well in this choppy market - next level to conquer is 50 - then 100 will be taken out - enjoy the ride with this juggernaut - we're goin higher - much higher.
  • e
    eduardo r
    Paul Singer watchful eye is causing Emma and mgmt to move in the right direction. GSK now is simply catching up with AZN after years of going nowhere.
  • c
    GSK has been and will be going nowhere for a long time, (ok it may go down a lot). Last year they changed the payment terms they give to doctors offices down to 60 days from 90.
    A lot of doctors offices then switched to Sanofi vaccines.
    Switching regimes is not easy for physicians offices, so it’s not that they will switch back anytime soon.
    Screw the customer and lose business.